Search Results for “Johnson ” – Page 28 – media

Veracyte, J&J team up on early lung cancer detection

The plan is to create new “interventions" using "field of injury" technology to catch molecular changes in the lining of the respiratory tract, which can indicate cancer or cancer-related changes in the lung.
- Source: https://www.fiercebiotech.com/medtech/veracyte-j-j-team-up-early-lung-cancer-detection
- 2,066
- January 28, 2019
diagnostics genome sequencing Johnson & Johnson lung cancer Veracyte
J&J Prepares for Appeal after Judge’s Multibillion-Dollar Verdict Against its Talc Defence

The jury at the St. Louis court announced its verdict against J&J last month, giving a major blow to the company as it now has to pay about $4.7 billion to 22 women or their loved-ones for the claim that it’s talc caused ovarian cancer.
- Source: FiercePharma
- 889
- August 27, 2018
cancer Company Insight Johnson & Johnson lawsuit
NASA Grant Approval for Visualdx to Devise Diagnostic Tool for Astronauts

Astronauts at the International Space Station are dependent upon telemedicine for all kinds of illness. However, according to Dr. Shannan Moynihan, the deputy chief of space and occupational medicine from the NASA Johnson Space Centre, although effective, telemedicine has its limits.
- Source: MobiHealthNews
- 570
- August 15, 2018
Company Insight NASA Telemedicine
HitGen and Merck Collaborates For DNA Library Screening

HitGen and Merck have updated their licensing agreement to a full-fledged drug discovery collaboration in order to screen DNA-encoded libraries for new small-molecule assets.
- Source: FierceBiotech
- 1,003
- August 8, 2018
biotech China Company Insight Merck
Janssen, Bayer Plans to Shut South Korean Plants Seeing a Plunging Demand

Janssen Korea becomes yet another drugmaker to shut its Hyangnam plant in Hwaseong, South Korea, by 2021, stranding an uncounted number of employees.
- Source: FiercePharma
- 684
- August 8, 2018
Company Insight pharmaceutical company South Korea
U.S. Insurers Baffled on Revelation of $4.7 billion J&J Talc Judgement

Wall Street is unclear whether the U.S. insurance industry will have to pay any costs from the $4.69 billion verdict against Johnson & Johnson granted to customers and their families who alleged that asbestos-adulterated talc leads to ovarian cancer.
- Source: Reuters
- 870
- August 3, 2018
cancer Company Insight Johnson & Johnson lawsuit
Filing Lawsuit Against Drugmakers for Funding Terrorism

Last year, around 100 veterans filed a bombshell lawsuit against several drugmakers, by accusing that they funded terrorism by paying high bribes to win contracts with the Iraqi Ministry of Health. At present, the Department of Justice is investigating similar accusations, as per AstraZeneca securities filing which says that it's part of the probe.
- Source: FiercePharma
- 1,046
- August 3, 2018
AstraZeneca Company Insight pharmaceutical
Clinical Innovations enters China with new Shanghai Subsidiary

Clinical Innovations has launched its new subsidiary in Shanghai to grow in the Chinese labor and delivery market, expanding its global footprint.
- Source: FierceBiotech
- 1,107
- August 2, 2018
China Company Insight medical device
Merck Presents 96-Week Doravirine HIV Data Three Months before PDUFA Date

96-week data on doravirine, Merck’s HIV drug, was posted by the drugmaker recently. Merck expects it to outrun drugs like Bristol-Myers Squibb’s Sustiva in combination regimens and antiretroviral drugs from AbbVie and Johnson & Johnson in viral suppression.
- Source: FierceBiotech
- 897
- July 27, 2018
HIV Merck Researches
Karyopharm Seeks FDA Approval for Selinexor Drug for Multiple Myeloma

The Newton Massachusetts-based company, Karyopharm Therapeutics, who developed a new class of drugs to treat multiple myeloma, is in the process of submitting a new drug application to the FDA for their selinexor drug.
- Source: MedCityNews
- 411
- July 24, 2018
cancer CAR-T therapies FDA New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.